# Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

> **NCT07063056** · NA · RECRUITING · sponsor: **Medinutra LLC** · enrollment: 64 (estimated)

## Conditions studied

- Triglycerides

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin (Longvida™)
- **DIETARY_SUPPLEMENT:** Half Dose Curcumin (Longvida™)
- **DIETARY_SUPPLEMENT:** Astaxanthin
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT07063056
- **Lead sponsor:** Medinutra LLC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2025-11-15
- **Final completion:** 2025-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063056, "Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07063056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*